RXi Pharmaceuticals, Philips deal

The companies will evaluate the use of RXi's self-delivering rxRNA (sd-rxRNA) with Royal Philips' ultrasound technology to achieve targeted delivery and monitoring of RNAi-based compounds in vivo. Fin...